Skip to main content
. 2019 Dec 26;25(7):560–e1006. doi: 10.1634/theoncologist.2019-0932
All Cycles
Name NC/NA 1 2 3 4 5 All grades
Injection site reaction 0% 40% 60% 0% 0% 0% 100%
Fatigue 40% 50% 10% 0% 0% 0% 60%
Chills 50% 50% 0% 0% 0% 0% 50%
Fever 60% 20% 20% 0% 0% 0% 40%
Headache 70% 20% 10% 0% 0% 0% 30%
Abdominal soft tissue necrosis 90% 10% 0% 0% 0% 0% 10%
Rash maculo‐papular 90% 10% 0% 0% 0% 0% 10%
Depressed level of consciousness 90% 0% 0% 10% 0% 0% 10%
Testicular pain 90% 10% 0% 0% 0% 0% 10%
Pleural effusion 90% 0% 10% 0% 0% 0% 10%
Weight gain 90% 10% 0% 0% 0% 0% 10%
Localized edema 90% 0% 10% 0% 0% 0% 10%
Myalgia 80% 10% 10% 0% 0% 0% 20%
Edema limbs 80% 10% 10% 0% 0% 0% 20%
Edema trunk 90% 10% 0% 0% 0% 0% 10%
Cough 90% 10% 0% 0% 0% 0% 10%
Respiratory, thoracic, and mediastinal disorders—nasal congestion 80% 20% 0% 0% 0% 0% 20%

Highest adverse event grade is noted for each patient. Adverse events at least possibly related to research.

Abbreviation: NC/NA, no change from baseline/no adverse event.